Citations

Showing 10 of 108104 citations.

Early History of Home Parenteral Nutrition: From Hospital to Home
Steiger, Ezra, Hurt, Ryan T.

Mayo Clinic

Nutrition in Clinical Practice | August 23, 2018 | Volume: 33 | Issue: 5 | Pages: 598-613

10.1002/ncp.10180 | PMID 30137646 Get It

AbstractTechnologic advances in the past century have led to the ability to safely deliver parenteral nutrition (PN) to hospitalized patients. Key breakthroughs included the development of saline and glucose infusions, infusion pumps, macronutrients (lipids, dextrose, and amino acids), and central venous catheters. In the 1960s, centrally delivered PN was performed in short‐term hospitalized patients by Lincoln James Lawson (North Staffordshire Royal Infirmatory, United Kingdom) and long‐term patients by Stanley Dudrick (University of Pennsylvania, United States). These early studies showed that a system was needed that would allow patients with intestinal failure to be discharged from the hospital and receive home PN (HPN). In the late 1960s and early 1970s, Belding Scribner, Maurice Shils, Khursheed Jeejeebhoy, Marvin Ament, Dudrick, and their teams discharged patients from the hospital who then self‐administered HPN. Shortly after these early cases of HPN, multidisciplinary centers were established first in North America, and later in Europe, to manage these complex cases. The current article describes the patients treated by these early HPN pioneers, in addition to subsequent case series reported by them and others.
International multicenter observational study on assessment of ventilatory management during general anaesthesia for robotic surgery and its effects on postoperative pulmonary complication (AVATaR): study protocol and statistical analysis plan
Queiroz, Verônica Neves Fialho , Barbosa, Rogerio Póvoa, Takaoka, Flávio , Baerdemaeker, Luc De , Cesar, Daniel Souza, D’Orto, Ulisses Cardoso, Galdi, José Roberto, Hemmes, Sabrine N.T. , Hollman, Markus W, Kalmar, Alain F. , Moura, Lucas A B de, Mariano, Renato, Matot, Idit , Mazzinari, Guido , Mills, Gary , Posso, Irimar de Paula, Teruya, Alexandre , Melo, Marcos Francisco Vidal, Treschan, Tanja A. , Eidelman, Leonid A., Chen, Lee‐lynn , Lee, Jae Woo , Irujo, J.J. Ariño, Tena, Beatriz , Groeben, Harald , Pelosi, Paolo , Schultz, Marcus J. , Costa, Luiz Guilherme Villares da , Cesar, Daniel Souza, Gottumukkala, Vijaya N. R. , Cata, Juan P. , Moura, Lucas Araújo de Borges , Šprung, Juraj , Weingarten, Toby N. , Koopman, Seppe , Abreu, Marcelo Gama de , Neto, Ary Serpa , Schultz, Marcus J

Mayo Clinic

BMJ Open | August 23, 2018 | Volume: 8 | Issue: 8 | Pages: e021643

10.1136/bmjopen-2018-021643 | PMID 30139899 Get It

Introduction Robotic-assisted surgery (RAS) has emerged as an alternative minimally invasive surgical option. Despite its growing applicability, the frequent need for pneumoperitoneum and Trendelenburg position could significantly affect respiratory mechanics during RAS. AVATaR is an international multicenter observational study aiming to assess the incidence of postoperative pulmonary complications (PPC), to characterise current practices of mechanical ventilation (MV) and to evaluate a possible association between ventilatory parameters and PPC in patients undergoing RAS. Methods and analysis AVATaR is an observational study of surgical patients undergoing MV for general anaesthesia for RAS. The primary outcome is the incidence of PPC during the first five postoperative days. Secondary outcomes include practice of MV, effect of surgical positioning on MV, effect of MV on clinical outcome and intraoperative complications. Ethics and dissemination This study was approved by the Institutional Review Board of the Hospital Israelita Albert Einstein. The study results will be published in peer-reviewed journals and disseminated at international conferences. Trial registration number NCT02989415 ; Pre-results.
Gastrointestinal: Caval tumor thrombus and duodenal metastasis from endometrial carcinoma
Huynh, Kenneth N. , Wu, KJ, Nguyen, Ba D.

Mayo Clinic

Journal of Gastroenterology and Hepatology | August 23, 2018 | Volume: 34 | Issue: 2 | Pages: 309-309

10.1111/jgh.14411 | PMID 30136307 Get It

Integrating the Epigenome to Identify Drivers of Hepatocellular Carcinoma
Hlady, Ryan A. , Sathyanarayan, Aishwarya , Thompson, Joyce J. , Zhou, Dan , Wu, Qunfeng , Pham, Kien , Lee, Jeong‐Heon , Liu, Chen , Robertson, Keith D. , Robertson, Keith D , Lee, Jeong-Heon , Liu, Chen

Mayo Clinic

Hepatology | August 23, 2018 | Volume: 69 | Issue: 2 | Pages: 639-652

10.1002/hep.30211 | PMID 30136421 Get It

Disruption of epigenetic mechanisms has been intimately linked to the etiology of human cancer. Understanding how these epigenetic mechanisms (including DNA methylation [5mC], hydroxymethylation [5hmC], and histone post‐translational modifications) work in concert to drive cancer initiation and progression remains unknown. Hepatocellular carcinoma (HCC) is increasing in frequency in Western countries but lacks efficacious treatments. The epigenome of HCC remains understudied. To better understand the epigenetic underpinnings of HCC, we performed a genome‐wide assessment of 5mC, 5hmC, four histone modifications linked to promoter/enhancer function (H3K4me1, H3K27ac, H3K4me3, and H3K27me3), and transcription across normal, cirrhotic, and HCC liver tissue. Implementation of bioinformatic strategies integrated these epigenetic marks with each other and with transcription to provide a comprehensive epigenetic profile of how and when the liver epigenome is perturbed during progression to HCC. Our data demonstrate significant deregulation of epigenetic regulators combined with disruptions in the epigenome hallmarked by profound loss of 5hmC, locus‐specific gains in 5mC and 5hmC, and markedly altered histone modification profiles, particularly remodeling of enhancers. Data integration demonstrates that these marks collaborate to influence transcription (e.g., hyper‐5hmC in HCC‐gained active enhancers is linked to elevated expression) of genes regulating HCC proliferation. Two such putative epigenetic driver loci identified through our integrative approach, COMT and FMO3 , increase apoptosis and decrease cell viability in liver‐derived cancer cell lines when ectopically re‐expressed. Conclusion : Altogether, integration of multiple epigenetic parameters is a powerful tool for identifying epigenetically regulated drivers of HCC and elucidating how epigenome deregulation contributes to liver disease and HCC.
Molecular and Ultrastructural Features of Diffuse Intrapulmonary Malignant Mesothelioma
Larsen, Brandon T. , Roden, Anja C. , Sukov, William R. , Thirumala, Seshadri , Colby, Thomas V. , Tazelaar, Henry D. , Smith, Maxwell L. , Hornychová, Helena , Tazelaar, Henry D.

Mayo Clinic

American Journal of Surgical Pathology | August 23, 2018 | Volume: 43 | Issue: 1 | Pages: 147-150

10.1097/pas.0000000000001143 | PMID 30138217 Get It

Seizure-related crashes
Sirven, Joseph I , Payne, Eric T.

Mayo Clinic

Neurology | August 22, 2018 | Volume: 91 | Issue: 12 | Pages: 543-544

10.1212/wnl.0000000000006188 | PMID 30135259 Get It

Ubiquitous yet unseen: microvascular endothelial dysfunction beyond the heart
Lerman, Lilach O. , Corban, Michel , Lerman, Amir

Mayo Clinic

European Heart Journal | August 22, 2018 | Volume: 39 | Issue: 46 | Pages: 4098-4100

10.1093/eurheartj/ehy576 | PMID 30165379 Get It

Incidence of Acute Kidney Injury Among Critically Ill Patients With Brief Empiric Use of Antipseudomonal β-Lactams With Vancomycin
Schreier, Diana J., Sakhuja, Ankit , Mara, Kristin C. , Tootooni, M. Samie , Personett, Heather A. , Nelson, Sarah , Steckelberg, James M., Tande, Aaron J. , Frazee, Erin N. , Tootooni, Mohammad S, Tande, Aaron , Mara, Kristin C , Kashani, Kianoush , Rule, Andrew D.

Mayo Clinic

Clinical Infectious Diseases | August 22, 2018 | Volume: 68 | Issue: 9 | Pages: 1456-1462

10.1093/cid/ciy724 | PMID 30165426 Get It

AbstractBackgroundNephrotoxins contribute to 20%–40% of acute kidney injury (AKI) cases in the intensive care unit (ICU). The combination of piperacillin-tazobactam (PTZ) and vancomycin (VAN) has been identified as nephrotoxic, but existing studies focus on extended durations of therapy rather than the brief empiric courses often used in the ICU. The current study was performed to compare the risk of AKI with a short course of PTZ/VAN to with the risk associated with other antipseudomonal β-lactam/VAN combinations.MethodsThe study included a retrospective cohort of 3299 ICU patients who received ≥24 but ≤72 hours of an antipseudomonal β-lactam/VAN combination: PTZ/VAN, cefepime (CEF)/VAN, or meropenem (MER)/VAN. The risk of developing stage 2 or 3 AKI was compared between antibiotic groups with multivariable logistic regression adjusted for relevant confounders. We also compared the risk of persistent kidney dysfunction, dialysis dependence, or death at 60 days between groups.ResultsThe overall incidence of stage 2 or 3 AKI was 9%. Brief exposure to PTZ/VAN did not confer a greater risk of stage 2 or 3 AKI after adjustment for relevant confounders (adjusted odds ratio [95% confidence interval] for PTZ/VAN vs CEF/VAN, 1.11 [.85–1.45]; PTZ/VAN vs MER/VAN, 1.04 [.71–1.42]). No significant differences were noted between groups at 60-day follow-up in the outcomes of persistent kidney dysfunction (P = .08), new dialysis dependence (P = .15), or death (P = .09).ConclusionShort courses of PTZ/VAN were not associated with a greater risk of short- or 60-day adverse renal outcomes than other empiric broad-spectrum combinations.
Risks of Colorectal Cancer and Cancer-Related Mortality in Familial Colorectal Cancer Type X and Lynch Syndrome Families
Choi, Yun‐Hee , Lakhal‐Chaieb, Lajmi , Król, Agnieszka , Buchanan, Daniel D. , Ahnen, Dennis J. , Win, Aung Ko , Jenkins, Mark A. , Lindor, Noralane M. , Briollais, Laurent , Buchanan, Daniel D , Win, Aung K , Jenkins, Mark A , Yu, Bing , Marchand, Loı̈c Le , Newcomb, Polly A.

Mayo Clinic

JNCI: Journal of the National Cancer Institute | August 22, 2018 | Volume: 111 | Issue: 7 | Pages: 675-683

10.1093/jnci/djy159 | PMID 30380125 Get It

Abstract Background The risk of cancers is well characterized in Lynch syndrome (LS) families but has been less studied in familial colorectal cancer type X (FCCTX) families. Methods In this article, we compare the risk estimates of first and second colorectal cancers (CRCs) in 168 FCTTX and 780 LS families recruited through the Colon Cancer Family Registry as well as the risk of cancer-related deaths and disease-free survival (DFS) after a first CRC. Our methodology is based on a survival analysis approach, developed specifically to model the occurrence of successive cancers (ie, first and second CRCs) in the presence of competing risk events (ie, death from any causes). Results We found an excess risk of first and second CRC in individuals with LS compared to FCCTX family members. However, for an average age at first CRC of 60 years in FCCTX families and 50 years in LS families, the DFS rates were comparable in men but lower in women from FCCTX vs LS families, eg , 75.1% (95% confidence interval [CI] = 69.0% to 80.9%) vs 78.9% (95% CI = 76.3% to 81.3%) for the 10-year DFS. The 10-year risk of cancer-related death was higher in FCCTX families vs LS families, eg, 15.4% in men (95% CI = 10.9% to 19.8%) and 19.3% in women (95% CI = 13.6% to 24.7%) vs 8.9% (95% CI = 7.5% to 11.4%) and 8.7% (95% CI = 7.1% to 10.8%), respectively. Conclusions Individuals with CRCs arising in the context of FCCTX do not experience the same improved DFS and overall survival of those with LS, and that difference may be relevant in management decisions.
Revitalized and synovialized allograft for intrasynovial flexor tendon reconstruction in an in vivo canine model
Zhang, Tao , Lu, Cheng‐Chang , Reisdorf, Ramona L., Thoreson, Andrew R. , Gingery, Anne , Moran, Steven L. , Amadio, Peter C. , Zhao, Chunfeng , Gingery, Anne

Mayo Clinic

Journal of Orthopaedic Research | August 22, 2018 | Volume: 36 | Issue: 8 | Pages: 2218-2227

10.1002/jor.23889 | PMID 29575268 Get It

ABSTRACTThis study was to test our hypothesis that flexor tendon reconstruction with an allograft revitalized with bone marrow stromal cells (BMSCs) and synovialized with carbodiimide derivatized autologous synovial fluid (cd‐SYN) would result in better digit functional restoration than the conventional allograft tendon. A total of 32 flexor digital profundus tendons from the second and fifth digit of 16 dogs were created a repair failure model first. Then, failed‐repaired tendons were reconstructed with either a revitalized‐synovialized allograft tendon or a clinical standard autograft tendon (control group). The allograft tendon was seeded with autologous BMSCs in multiple slits and the graft surface was coated with cd‐SYN. A 6 weeks after tendon reconstruction, the digits were harvested and evaluated for digit function, adhesion status, tendon gliding resistance, attachment strength, cell viability, and histologic factors. The allograft group had significantly improved digit function compared with the control group through decreased work of flexion, increased digit range of motion under 2‐Newton force, and less adhesion score (p < .05). However, the distal attachment‐site strength and stiffness in the allograft tendon were significantly weaker than the autografts (p < .05). No significant difference was found for gliding resistance. Histologically, allograft tendons coated with allograft had smoother surfaces and showed tendon‐to‐bone and tendon‐to‐tendon incorporation. Viable BMSCs were found in the tendon slits 6 weeks after the graft. In conclusion, cellular lubricant‐based modification of allograft tendons improved digit function and reduced the adhesions compared with autograft for flexor tendon reconstruction. However, improvement of graft‐to‐host tendon healing is still challenging. © 2018 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 36:2218–2227, 2018.